Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-01
2011-03-01
Chandrakumar, Nizal S (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S119000, C514S300000, C514S303000
Reexamination Certificate
active
07897771
ABSTRACT:
Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases.
REFERENCES:
patent: 3992544 (1976-11-01), Archibald et al.
patent: 5053508 (1991-10-01), Schiehser et al.
patent: 5648352 (1997-07-01), Bock et al.
patent: 5663178 (1997-09-01), Audia et al.
patent: 5843912 (1998-12-01), Hosmane et al.
patent: 6057325 (2000-05-01), Kennis et al.
patent: 6177443 (2001-01-01), Madsen et al.
patent: 6559174 (2003-05-01), Lin et al.
patent: 7579470 (2009-08-01), Dvorak et al.
patent: 2003/0199542 (2003-10-01), Woods et al.
patent: 2003/0199544 (2003-10-01), Woods et al.
patent: 2005/0101594 (2005-05-01), Binch et al.
patent: 2006/0100233 (2006-05-01), Villa et al.
patent: 2006/0135508 (2006-06-01), Villa et al.
patent: 2006/0241065 (2006-10-01), Hosmane et al.
patent: 0086422 (1983-08-01), None
patent: 0086422 (1987-09-01), None
patent: 0905 136 (1999-03-01), None
patent: WO 94 14777 (1994-07-01), None
patent: WO 98 40385 (1998-09-01), None
patent: WO 02 066484 (2002-08-01), None
patent: WO 03 051797 (2003-06-01), None
patent: WO 03 099822 (2003-12-01), None
patent: WO 03 101989 (2003-12-01), None
patent: WO 2004 013144 (2004-02-01), None
patent: WO 2004 014374 (2004-02-01), None
patent: 2004/094429 (2004-04-01), None
patent: WO 2004 094429 (2004-11-01), None
patent: WO 2005 009387 (2005-02-01), None
patent: WO 2005 030776 (2005-04-01), None
Abdel-Magid, A. F. et al. Reductive Amination of Aldehydes and Ketones With Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures. J. Org. Chem. 1996, 61(11), 3849-3862.
Berge et al “Pharmaceutical Salts” J Pharm Sci 1977 vol. 11 pp. 1-19.
Bourrain, S. et al. Regioselective Rapid Analogue Syntheses of 1-Methyl-3,5-Diarylpyrazoles Via Palladium-Catalysed Coupling to 3(5)-Pyrazolyl Nonaflates. Synlett. 2004, 5, 795-798.
Cheng et al. “Relationship Between the Inhibition Constant (K1) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (150) of an Enzymatic Reaction” Biochem Pharmacol 1973 vol. 22 pp. 3099-3108.
Ghali, N. I. and D.L. Fenton. High-Yielding Synthesis of Monoalkylhydrazines. J. Org. Chem. 1981, 46(26), 5413-4514.
Greene et al Protecting Groups in Organic Synthesis 1999 3rd ED T.W. Greene & P.G.M. Wuts John Wiley & Sons.
Hoyer, D. et al. Molecular, Pharmacological and Functional Diversity of 5-HT Receptors. Pharmacol. Biochem. Behav. 2002, 71(4), 533-554.
Jerman et al “Pharmacological Characterisation of Human 5-HT2 Receptor Subtypes” 2001 Eur J Pharmacol 2001 vol. 414 pp. 23-30.
Lim, S. et al. Reaction of Cyclohexanones Imines With Substituted Nitroolefins. New Synthesis of Tetrahydroindole Derivatives. Tetrahedron Lett. 1999, 40(22), 4177-4180.
Moriya, T. et al. Studies of Seven-Membered Heterocyclic Compounds Containing Nnitrogen. IX. The Synthesis of 5-Ethoxycarbonyl-1-Azacycloheptan-4-One and Its Derivatives. Bull. Chem. Soc. JPN. 1968, 41(1), 230-231. (For Some Reason the Scan the Chemists Gave me is Upside Down in Adobe).
Oh-E, T. et al. Palladium-Catalyzed Cross-Coupling Reaction of Organoboron Compounds With Organic Triflates. J. Org. Chem. 1993, 58(8), 2201-2208.
Porter et al. “Functional Characterization of Agonists at Recombinant Human 5-HT2A, 5-HT2B and 5-HT2C Receptors in CHO-K1 Cells” British Journal of Pharmacology 1999 vol. 128 pp. 13-20.
Radinov et al. STN Accession No. 988:111448, Abstract of Journal of Molecular Structure (1987), 158, 99-108.
Roglans, A. et al. Preparation of 3-Pyrrolidone and 4-Perhydroazepinone. Synth. Commun. 1992, 22(9), 1249-1258.
Roth, B.L. et al. The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? Neuroscientist 2000, 6(4), 252-262.
Sasatani et al “Diisobutylaluminum Hydride A Novel Reagent for the Reduction of Oximes” Tetrahedron Lett 1983 vol. 24(43) pp. 4711-4712.
Schotte et al “Risperidone Compared With New and Reference Antipsychotic Drugs: in Vitro and in Vivo Receptor Binding” Psychopharmacology 1996 vol. 124 pp. 57-73.
Stahl S.M. Essential Psychopharmacology 2000 2nd Ed Cambridge University Press Cambridge UK.
Vidal, J. et al. Electrophilic Amination: Preparation and Use of N-Boc-3-(4-Cyanophenyl)Oxaziridine, a New Reagent That Transfers a N-Boc Group to N- and C-Nucleophiles. J. Org. Chem. 1993, 58(18), 4791-4793.
Winters, G. et al. Synthesis, in Vitro [3H]Prazosin Displacement, and in Vivo Activity of 3-Aryl-4,5,6,7-Tetrahydropyrazolo[4,3-C]Pyridines, a New Class of Antihypertensive Agents. J. Med. Chem. 1985, 28(7), 934-940.
International Search Report 12 14 2005 PCT/US2004/030190.
Carruthers Nicholas I.
Chai Wenying
Deng Xiaohu
Dvorak Curt A.
Kwok Annette K.
Atkins Michael J.
Chandrakumar Nizal S
Janssen Pharmaceutica NV
LandOfFree
Fused heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619996